zoledronic acid has been researched along with Melanoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barna, G; Çakır, U; Érsek, B; Faqi, S; Gyöngy, M; Hajdara, A; Kárpáti, S; Mayer, B; Németh, K; Silló, P; Széky, B | 1 |
| Alvarado, M; Bueno, S; González, L; Ramírez, M; Sierra, M | 1 |
| Amaravadi, R; Dong, L; Fan, Y; Guo, W; Guo, Y; Huang, AC; Huang, L; Karakousis, G; Lin, S; Liu, Q; Lu, H; Luo, L; Ou, L; Schuchter, L; Shi, C; Wang, H; Xu, X; Yin, X; Zhang, J; Zheng, C; Zhu, J | 1 |
| Achel, DG; Alcaraz, M; Alcaraz-Saura, M; Olivares, A | 1 |
| Cervini, G; Morilla, MJ; Romero, EL; Schilrreff, P | 1 |
| Deng, X; Eiraku, Y; Nicol, AJ; Nieda, M; Terunuma, H | 1 |
| Consolini, R; Failli, A; Legitimo, A; Orsini, G; Romanini, A | 1 |
| Berger, W; Dobos, J; Döme, B; Garay, T; Hegedűs, B; Juhász, É; Kenessey, I; Klepetko, W; László, V; Molnár, E; Réti, A; Rózsás, A; Tímár, J; Tóvári, J | 1 |
| Harries, M; Hayday, A; Laggner, U; Lopez, JS; Nestle, FO; O'Doherty, MJ; Perera, G; Sita-Lumsden, A; Warbey, VS | 1 |
| De Rossi, C; Nitti, D; Pigozzo, J; Rossi, CR; Sileni, VC | 1 |
| Acland, K; Calonje, E; Harries, M; O'Doherty, M; Perez, A; Szyszko, T; Turajlic, S | 1 |
| Galimberti, S; Pacini, S; Petrini, I; Petrini, M; Romanini, A; Taddei, MR | 1 |
| Forsea, AM; Geilen, CC; Müller, C; Orfanos, CE; Riebeling, C | 1 |
| Conroy, M; Cree, IA; Fernando, A; Knight, LA; Kurbacher, CM; Polak, M | 1 |
1 review(s) available for zoledronic acid and Melanoma
| Article | Year |
|---|---|
Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy.
Topics: Apoptosis; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Lung Neoplasms; Melanoma; Middle Aged; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand; Zoledronic Acid | 2009 |
13 other study(ies) available for zoledronic acid and Melanoma
| Article | Year |
|---|---|
Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model.
Topics: Cancer-Associated Fibroblasts; DiGeorge Syndrome; Fibroblasts; Humans; Melanoma; Tumor Microenvironment; Zoledronic Acid | 2023 |
Hypercalcemia of Malignancy in a Patient with Hypoparathyroidism: A Complicated but Treatable Condition.
Topics: Bone Density Conservation Agents; Calcitriol; Diphosphonates; Eye Neoplasms; Humans; Hypercalcemia; Hypoparathyroidism; Male; Melanoma; Middle Aged; Noonan Syndrome; Zoledronic Acid | 2019 |
Dichotomous and stable gamma delta T-cell number and function in healthy individuals.
Topics: Adult; Biomarkers; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coculture Techniques; Cytotoxicity, Immunologic; Female; Healthy Volunteers; Humans; Immunologic Memory; Immunophenotyping; Intraepithelial Lymphocytes; Lymphocyte Activation; Lymphocyte Count; Male; Melanoma; Middle Aged; Phenotype; Skin Neoplasms; Young Adult; Zoledronic Acid | 2021 |
Effects of bisphosphonates in combination with ionizing radiation and antioxidants on the growth of prostate and melanoma cells lines.
Topics: Animals; Antioxidants; Apigenin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Male; Melanoma; Mice; Pamidronate; Prostatic Neoplasms; Radiation, Ionizing; Skin Neoplasms; Zoledronic Acid | 2013 |
Enhanced antimelanoma activity of methotrexate and zoledronic acid within polymeric sandwiches.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Diphosphonates; Drug Screening Assays, Antitumor; Endocytosis; Humans; Imidazoles; Melanoma; Methotrexate; Polymers; Spectroscopy, Fourier Transform Infrared; Zoledronic Acid | 2014 |
Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Topics: CD56 Antigen; CD8-Positive T-Lymphocytes; Dendritic Cells; Diphosphonates; Flow Cytometry; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-A2 Antigen; Humans; Imidazoles; Immunotherapy; Interferon-alpha; Interleukin-2; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lymphocytes; Melanoma; Monocytes; Peptides; Phenotype; Receptors, Antigen, T-Cell, gamma-delta; Skin Neoplasms; Zoledronic Acid | 2015 |
The effects of zoledronate on monocyte-derived dendritic cells from melanoma patients differ depending on the clinical stage of the disease.
Topics: Cell Differentiation; Cell Proliferation; Cells, Cultured; Dendritic Cells; Diphosphonates; Disease Progression; Endocytosis; Female; Humans; Imidazoles; Lipopolysaccharide Receptors; Lymphocyte Activation; Male; Melanoma; Neovascularization, Pathologic; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Tumor Microenvironment; Zoledronic Acid | 2014 |
Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Diphosphonates; GTP Phosphohydrolases; Humans; Imidazoles; Male; Melanoma; Membrane Proteins; Mice; Mice, SCID; Mutation; Prenylation; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Zoledronic Acid | 2015 |
Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion.
Topics: Antineoplastic Agents, Alkylating; Bone Density Conservation Agents; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Diphosphonates; Humans; Imidazoles; Male; Melanoma; Melphalan; Positron-Emission Tomography; Skin Neoplasms; Tibia; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult; Zoledronic Acid | 2009 |
Generalized melanosis and melanuria in a patient with metastatic melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Diphosphonates; Humans; Imidazoles; Male; Melanins; Melanoma; Melanosis; Middle Aged; Positron-Emission Tomography; Skin Neoplasms; Zoledronic Acid | 2010 |
Impaired function of gamma-delta lymphocytes in melanoma patients.
Topics: Adult; Bone Density Conservation Agents; Case-Control Studies; Cell Line, Tumor; Cytotoxicity, Immunologic; Diphosphonates; Female; Flow Cytometry; Humans; Imidazoles; Immunophenotyping; Interleukin-2; Lymphocyte Count; Lymphocytes; Male; Melanoma; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta; Skin Neoplasms; Zoledronic Acid | 2011 |
Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.
Topics: Antimetabolites; Antineoplastic Agents; Cell Cycle; Clodronic Acid; Diphosphonates; Disease Progression; Humans; Imidazoles; Melanoma; Nitrogen; Pamidronate; Skin Neoplasms; Tumor Cells, Cultured; Zoledronic Acid | 2004 |
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caspase 3; Caspase 7; Caspases; Cell Line, Tumor; Cell Survival; Cisplatin; Clodronic Acid; Diphosphonates; Energy Metabolism; Female; Humans; Imidazoles; Inhibitory Concentration 50; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured; Zoledronic Acid | 2005 |